Evidence map›Paper›PMID 22376068›Full record

ArticleMolecular pharmaceutics2012

Raman microscopy for noninvasive imaging of pharmaceutical nanocarriers: intracellular distribution of cationic liposomes of different composition.

T Chernenko, R R Sawant, M Miljkovic, L Quintero, M Diem, V Torchilin

Abstract read
In one paragraph

Article in Molecular pharmaceutics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Raman Imaging of Nanocarriers for Drug Delivery.Nanomaterials (Basel, Switzerland) · 2019
    Review
  7. Article
  8. Circulating Lipoproteins: A Trojan Horse Guiding Squalenoylated Drugs to LDL-Accumulating Cancer Cells.Molecular therapy : the journal of the American Society of Gene Therapy · 2017
    Article
  9. Review
  10. Article
  11. Article
  12. NEXT STEP IN DRUG DELIVERY: GETTING TO INDIVIDUAL ORGANELLES.Drug delivery and translational research · 2012
    Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

T ChernenkoCenter for Pharmaceutical Biotechnology and Nanomedicine, Pharmaceutical Department, Northeastern University, Boston, Massachusetts 02115, USA. taty.chernenko@gmail.com
R R Sawant
M Miljkovic
L Quintero
M Diem
V Torchilin

Funding

Micro-Spectroscopy for Cytological Screening, and Staging of DiseaseR01CA090346 · NCI · NORTHEASTERN UNIVERSITY · PI DIEM, MAX · 2003 to 2010
$3.2M
Surface-modified pharmaceutical nanocarriers for subcellular targetingR01CA128486 · NCI · NORTHEASTERN UNIVERSITY · PI TORCHILIN, VLADIMIR P · 2008 to 2012
$1.8M
NCI NIH HHS CA 090346NCI NIH HHS CA128486-02S1NCI NIH HHS R01 CA090346NCI NIH HHS R01 CA128486
6 · The paper itself

Abstract

Nanotechnology is playing an increasing role in targeted drug delivery into pathological tissues. Drug-loaded pharmaceutical nanocarriers can be delivered into diseased sites by passive targeting (spontaneous accumulation of nanocarriers in the areas with affected vasculature) or by active targeting (via site-specific ligands attached to the surface of drug-loaded nanocarriers). Subsequent level of targeting requires cellular internalization of nanocarriers and their specific association with certain individual cell organelles. The control over intracellular distribution of pharmaceutical nanocarriers requires effective and noninvasive methods of their visualization inside cells. In an attempt to enhance cellular internalization of pharmaceutical nanocarriers and their association with mitochondria specifically, we have prepared three types of cationic liposomes and investigated their intracellular distribution. The analysis was performed using Raman microspectroscopy in order to provide morphological information as well as biochemical signatures of the sample. It was demonstrated that Raman microscopy allows evaluation of the extent of mitochondrial association depending on the liposome composition.

Indexed as

Drug CarriersHeLa CellsHumansLiposomesNanoparticlesSpectrum Analysis, RamanDrug CarriersLiposomes

Identifiers

PMID22376068
PMCPMC3405904

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.